Investors Purchase Large Volume of Aurora Cannabis Call Options (NASDAQ:ACB)

Aurora Cannabis Inc. (NASDAQ:ACB) saw some unusual options trading on Tuesday. Stock investors purchased 24,073 call options on the stock. This represents an increase of 38% compared to the typical volume of 17,462 call options.

Institutional Trading of Aurora Cannabis

Several large investors have recently added to or reduced their stakes in ACB. Yong Rong HK Asset Management Ltd purchased a new position in shares of Aurora Cannabis during the 3rd quarter worth $878,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Aurora Cannabis by 6.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,888,202 shares of the company’s stock worth $1,690,000 after purchasing an additional 172,049 shares during the period. Vontobel Holding Ltd. grew its holdings in shares of Aurora Cannabis by 67.5% during the 3rd quarter. Vontobel Holding Ltd. now owns 125,304 shares of the company’s stock worth $73,000 after purchasing an additional 50,500 shares during the period. Vanguard Personalized Indexing Management LLC purchased a new position in shares of Aurora Cannabis during the 4th quarter worth $42,000. Finally, Mackenzie Financial Corp purchased a new position in shares of Aurora Cannabis during the 4th quarter worth $98,000. 47.63% of the stock is currently owned by hedge funds and other institutional investors.

Aurora Cannabis Stock Down 3.0 %

Shares of NASDAQ:ACB opened at $7.20 on Thursday. The company has a quick ratio of 2.45, a current ratio of 3.79 and a debt-to-equity ratio of 0.14. The business has a fifty day moving average of $4.51 and a two-hundred day moving average of $4.56. The stock has a market cap of $392.69 million, a P/E ratio of -2.48 and a beta of 2.36. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $11.50.

Aurora Cannabis (NASDAQ:ACB) last issued its earnings results on Thursday, February 8th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.10). The company had revenue of $53.34 million during the quarter, compared to analysts’ expectations of $45.94 million. Aurora Cannabis had a negative net margin of 48.82% and a negative return on equity of 23.27%. On average, research analysts expect that Aurora Cannabis will post -0.85 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group upgraded Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Friday, February 9th.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.